| Members |
targetComponentId |
| Budesonide 1mg/2mL nebulization unit (product) |
Product containing precisely budesonide 500 microgram/1 milliliter conventional release solution for inhalation (clinical drug) |
| Budesonide 200mcg/spray powder (product) |
Budesonide 200 microgram/actuation powder for inhalation |
| Budesonide 200micrograms inhalation capsule (product) |
Budesonide 200 microgram/actuation powder for inhalation |
| Budesonide 200micrograms inhaler with spacer device (product) |
Budesonide 200 microgram/actuation solution for inhalation |
| Budesonide 2mg/100mL enema (product) |
Product containing only budesonide in rectal dose form (medicinal product form) |
| Budesonide 320mcg/formoterol 9mcg dry powder inhaler (product) |
Budesonide and formoterol only product in pulmonary dose form |
| Budesonide 400micrograms inhalation capsule (product) |
Budesonide 400 microgram/actuation powder for inhalation |
| Budesonide 500micrograms/2mL nebulization unit (product) |
Product containing precisely budesonide 250 microgram/1 milliliter conventional release solution for inhalation (clinical drug) |
| Budesonide 64mcg aqueous nasal spray (product) |
Product containing only budesonide in nasal dose form (medicinal product form) |
| Budesonide 64mcg conventional release nasal spray (product) |
Product containing only budesonide in nasal dose form (medicinal product form) |
| Budesonide 80mcg/formoterol 4.5mcg dry powder inhaler (product) |
Product containing precisely budesonide 80 microgram and formoterol fumarate dihydrate 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
| Budesonide 90micrograms dry powder for inhalation (product) |
Product containing only budesonide in pulmonary dose form (medicinal product form) |
| Budesonide+eformoterol fumarate dihydrate 400micrograms/12micrograms breath-actuated dry powder inhaler (product) |
Budesonide and formoterol only product in pulmonary dose form |
| Budgerigar droppings protein (substance) |
Budgerigar droppings |
| Bull sheath washing |
Cleaning of prepuce of penis |
| Bullera |
Genus Bullera (organism) |
| Bunyavirus serogroup Bunyamwera |
virus Bunyamwera (organisme) |
| Bupivacaine 0.105% infusion solution ampule (product) |
Bupivacaine hydrochloride 1.05 mg/mL solution for injection |
| Bupivacaine 3.75mg/mL(0.375%) injection solution (product) |
Bupivacaine only product in parenteral dose form |
| Bupivacaine hydrochloride + dextrose 7.5mg/82.5mg injection (product) |
Bupivacaine only product in parenteral dose form |
| Bupivacaine hydrochloride 0.1% infusion solution (product) |
Bupivacaine only product in parenteral dose form |
| Bupivacaine hydrochloride 0.125% infusion solution 250mL bag (product) |
Bupivacaine hydrochloride 1.25 mg/mL solution for injection |
| Bupivacaine hydrochloride 0.5%/epinephrine 50micrograms 10mL (1:200000) injection solution (product) |
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Bupivacaine hydrochloride 0.75% injection (product) |
Bupivacaine only product in parenteral dose form |
| Bupivacaine hydrochloride 0.75% injection solution ampule (product) |
Bupivacaine only product in parenteral dose form |
| Bupivacaine hydrochloride 2.5mg/epinephrine bitartrate 5mcg injection solution vial (product) |
Product containing only bupivacaine and epinephrine (medicinal product) |
| Bupivacaine hydrochloride 5mg/epinephrine 5mcg injection solution vial (product) |
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Bupivacaine hydrochloride 7.5mg/dextrose 82.5mg injection solution vial (product) |
Bupivacaine only product in parenteral dose form |
| Bupivacaine hydrochloride+epinephrine 0.75%/1:200000 injection (product) |
Product containing precisely bupivacaine hydrochloride 7.5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Buprenorphine 5microgram/hour transdermal patch (product) |
Product containing only buprenorphine in transdermal dose form (medicinal product form) |
| Buprenorphine hydrochloride + naloxone hydrochloride (product) |
médicament contenant buprénorphine et naloxone |
| Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet (product) |
Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet |
| Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet (product) |
Buprenorphine (as buprenorphine hydrochloride) 8 mg and naloxone hydrochloride 2 mg sublingual tablet |
| Bupropion hydrochloride 100mg m/r tablet (product) |
Product containing only bupropion in oral dose form (medicinal product form) |
| Bupropion hydrochloride 100mg prolonged-release oral tablet |
Product containing only bupropion in oral dose form (medicinal product form) |
| Bupropion hydrochloride 200mg m/r tablet (product) |
Product containing only bupropion in oral dose form (medicinal product form) |
| Bupropion hydrochloride 200mg prolonged-release oral tablet |
Product containing only bupropion in oral dose form (medicinal product form) |
| Bupropion hydrochloride 300mg m/r tablet (product) |
Product containing only bupropion in oral dose form (medicinal product form) |
| Bupropion hydrochloride 300mg prolonged-release oral tablet (product) |
Product containing only bupropion in oral dose form (medicinal product form) |
| Bupropion hydrochloride 50mg m/r tablet (product) |
Product containing only bupropion in oral dose form (medicinal product form) |
| Bupropion hydrochloride 50mg prolonged-release oral tablet (product) |
Product containing only bupropion in oral dose form (medicinal product form) |
| Burkholderia |
Genus Burkholderia (organism) |
| Burkholderia cocovenenans |
Burkholderia gladioli |
| Burkholderia vandii |
Burkholderia plantarii |
| Burn involving 10-14 percent of body surface, with 10-14 percent of body surface with full thickness burn |
Burn involving 10-19 percent of body surface, with 10-14 percent of body surface with full thickness burn (disorder) |
| Burn involving 15-19 percent of body surface, with 10-19 percent of body surface with full thickness burn |
Burn involving 10-19 percent of body surface, with 15-19 percent of body surface with full thickness burn (disorder) |
| Burn of larynx, trachea AND/OR lung (disorder) |
brulure |
| Burn of other internal organ, NEC |
Burn of internal organ |
| Burn to cornea - erythema |
Burn of cornea (disorder) |
| Burn to cornea - erythema |
Burn of cornea (disorder) |
| Buserelin 150micrograms spray (product) |
Buserelin only product |
| Buspirone hydrochloride 5mg tablet (product) |
Buspirone hydrochloride 5 mg oral tablet |
| Buspirone hydrochlorine (substance) |
Buspirone hydrochloride (substance) |
| Butabarbital sodium 30mg/5mL elixir (product) |
Product containing precisely secbutabarbital sodium 6 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Butorphanol tartrate 1mg/mL injection solution ampule (product) |
Butorphanol tartrate 1 mg/mL solution for injection |
| Butorphanol tartrate 2mg/mL injection solution ampule (product) |
Butorphanol only product in parenteral dose form |
| Buttock random pattern flap |
Random pattern flap |
| Butyl nitrate - non-pharmaceutical |
Butyl nitrate |
| Butyrophenone derivative antipsychotic agent (substance) |
Butyrophenone derivative |
| C/O - specified symptom findings |
symptôme rapporté par le patient ou le répondant |
| C1 esterase inhibitor 500 units powder for injection solution 8mL vial |
Product containing precisely human C1 esterase inhibitor 500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| CDC Corynebacterium group G-1 |
Corynebacterium accolens |
| CDC group DF-2 |
Capnocytophaga canimorsus |
| CDE genotype |
CDE haplotype (finding) |
| CDe genotype |
CDe haplotype (finding) |
| CTV3 ROOT (special concept) |
SNOMED CT Concept |
| Cabbage - dietary |
Cabbage (substance) |
| Cabergoline [parkinsons] (product) |
Product containing cabergoline (medicinal product) |
| Caffeine and sodium benzoate injection (substance) |
Product containing caffeine and sodium benzoate (medicinal product) |
| Caffeine containing substance - non-pharmaceutical |
Caffeine |
| Café-au-lait spots and ring chromosome 11 (disorder) |
Ring chromosome 11 syndrome |
| Calcipotriene 0.005%/betamethasone 0.064% topical suspension (product) |
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and calcipotriol 50 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
| Calcitonin, salmon 100unit/mL injection solution 1mL vial (product) |
Product containing precisely salmon calcitonin 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Calcitonin, salmon 200iu/mL spray (product) |
Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug) |
| Calcitonin, salmon 200unt/mL injection (product) |
Salmon calcitonin 200 unit/mL solution for injection |
| Calcitonin, salmon 200unt/mL injection solution 2mL vial (product) |
Salmon calcitonin 200 unit/mL solution for injection |
| Calcium analyte |
Calcium |
| Calcium antacid |
Calcium compound |
| Calcium carbonate+cholecalciferol 1.25g/11micrograms/sachet granules (product) |
Calcium carbonate 6.25 mg/mL and cholecalciferol 2.2 unit/mL oral solution |
| Calcium chloride 10% injection solution 10mL prefilled syringe (product) |
Product containing precisely calcium chloride 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Calcium hydroxyapatite microsphere suspension in aqueous based carrier 0.3mL prefilled syringe (product) |
Product containing only durapatite in parenteral dose form (medicinal product form) |
| Calcium hydroxyapatite microsphere suspension in aqueous based carrier 1.3mL prefilled syringe (product) |
Product containing only durapatite in parenteral dose form (medicinal product form) |
| Calcium pentétate trisodique |
Product containing pentetic acid (medicinal product) |
| Calcium phosphate+colecalciferol 3100mg/20micrograms/sachet powder for oral suspension (product) |
Product containing only calcium phosphate and colecalciferol (medicinal product) |
| Calculus - composition (qualifier value) |
Stone composition - finding |
| Calculus exam. general |
Calculus examination |
| Calculus examination NOS |
Calculus examination |
| Calculus examination NOS |
Calculus examination |
| Calculus examination general |
Calculus examination |
| Calculus gen. exam. NOS |
Calculus examination |
| Calculus general examination NOS |
Calculus examination |
| Calfactant intratracheal suspension 6mL vial (product) |
Product containing only calfactant (medicinal product) |
| Calicivirus group (organism) |
Family Caliciviridae (organism) |
| Calliphora erythrocephala |
Calliphora vicina |
| Callitrogae |
Genus Cochliomyia (organism) |
| Caloric intake, function (observable entity) |
Energy intake (observable entity) |
| Caloscypha fulgens (organism) |
Caloscypha fulgens (organism) |
| Calymmatobacterium granulomatis |
Klebsiella granulomatis |
| Campylobacter cinaedi |
Helicobacter cinaedi |
| Campylobacter fennelliae |
Helicobacter fennelliae |
| Campylobacter laridis |
Campylobacter lari |
FHIR